Anti-TNFalpha monoclonal antibody B-C7

Drug Profile

Anti-TNFalpha monoclonal antibody B-C7

Alternative Names: B-C7

Latest Information Update: 19 Feb 2008

Price : $50

At a glance

  • Originator OPi
  • Class Monoclonal antibodies
  • Mechanism of Action Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Graft-versus-host disease

Most Recent Events

  • 19 Dec 1996 Investigation in Graft-versus-host disease in European Union (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top